Indeed, a DNAm increase in the promoter of the ELOVL2 gene has been reported in the early stage of AD compared to controls, resulting in increased endoplasmic reticulum stress and mitochondrial dysfunction. This evidence concerns the gene ELOVL2 and Alzheimer disease.